文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

评估 Ki67 增殖指数和肿瘤浸润淋巴细胞在嗅神经母细胞瘤中的预后潜力。

Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.

机构信息

Department of Pathology, Institut Gustave Roussy, Villejuif, France.

Department of Otolaryngology - Head and Neck Surgery, Assistance Publique-Hopitaux de Paris, Lariboisière Hospital, Paris, France.

出版信息

Histopathology. 2019 Dec;75(6):853-864. doi: 10.1111/his.13954. Epub 2019 Oct 6.


DOI:10.1111/his.13954
PMID:31306501
Abstract

AIMS: Olfactory neuroblastomas (ONBs) are rare malignant tumours that arise in the nasal vault. To date, the Hyams grade remains the only widely used histological grading system. However, it is based only on morphological criteria, and has not been updated since 1988. The objective of this study was to explore the prognostic potential of the Ki67 proliferation index (PI) and tumour-infiltrating lymphocytes (TILs) in ONB. METHODS AND RESULTS: A retrospective study was conducted on a bicentric series of 45 cases. The Ki67 PI was determined by counting at least 1000 nuclei on whole slides. TILs were evaluated with CD20, CD4 and CD8 immunohistochemical markers on whole slides. In this series, Hyams grades I, II, III and IV accounted for 13.4%, 44.4%, 20% and 22.2% of all cases, respectively. The Ki67 PI ranged from 1 to 93; the Ki67 PI was significantly higher in Hyams grade III-IV ONBs than in Hyams grade I-II ONBs (P < 0.0001). A Ki67 PI of ≥25 was associated with poorer survival (P = 0.02). TILs were present in both stromal and intratumoral compartments, but were located predominantly in the stromal component of the tumour. The numbers of intratumoral CD8+ cells/mm and CD4+ cells/mm were greater in high-grade ONBs than in low-grade ONBs (P = 0.0015 and P = 0.043, respectively). The numbers of T cells/mm and B cells/mm were not associated with survival, but a CD4/CD8 ratio of >2 was significantly associated with shorter survival (P = 0.04). CONCLUSION: Our findings suggest that the Ki67 PI and TILs could be used as prognostic markers, as a potential alternative to the Hyams grade.

摘要

目的:嗅神经母细胞瘤(ONB)是一种罕见的恶性肿瘤,起源于鼻腔穹窿。迄今为止,Hyams 分级仍然是唯一广泛使用的组织学分级系统。然而,它仅基于形态学标准,自 1988 年以来并未更新。本研究的目的是探讨 Ki67 增殖指数(PI)和肿瘤浸润淋巴细胞(TILs)在 ONB 中的预后潜力。

方法和结果:对两个中心的 45 例病例进行了回顾性研究。通过在整个幻灯片上计数至少 1000 个细胞核来确定 Ki67 PI。TILs 用 CD20、CD4 和 CD8 免疫组化标志物在整个幻灯片上进行评估。在本系列中,Hyams 分级 I、II、III 和 IV 分别占所有病例的 13.4%、44.4%、20%和 22.2%。Ki67 PI 范围为 1 至 93;Hyams 分级 III-IV ONB 的 Ki67 PI 明显高于 Hyams 分级 I-II ONB(P<0.0001)。Ki67 PI≥25 与生存率较差相关(P=0.02)。TILs 存在于基质和肿瘤内部位,但主要位于肿瘤的基质成分中。高分级 ONB 的肿瘤内 CD8+细胞/mm 和 CD4+细胞/mm 数量高于低分级 ONB(P=0.0015 和 P=0.043)。T 细胞/mm 和 B 细胞/mm 的数量与生存率无关,但 CD4/CD8 比值>2 与生存率较短显著相关(P=0.04)。

结论:我们的研究结果表明,Ki67 PI 和 TILs 可用作预后标志物,作为替代 Hyams 分级的潜在方法。

相似文献

[1]
Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.

Histopathology. 2019-10-6

[2]
Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.

Endocr Pathol. 2022-6

[3]
Clincopathological analysis of olfactory neuroblastoma.

Brain Tumor Pathol. 2012-2-14

[4]
Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?

Ann Diagn Pathol. 2015-12

[5]
The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.

Oral Oncol. 2017-11

[6]
Prognostic significance of PD-1, CTLA-4, CD4, and CD8 expression in olfactory neuroblastoma.

Clin Neuropathol. 2023

[7]
Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.

Laryngoscope. 2000-8

[8]
Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.

Hum Pathol. 2018-5-25

[9]
[New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019-7

[10]
Clinical features and the molecular biomarkers of olfactory neuroblastoma.

Pathol Res Pract. 2018-8

引用本文的文献

[1]
Hypoosmolar Hyponatremia as Presenting Symptom of a Rare Case of Olfactory Neuroblastoma.

JCEM Case Rep. 2025-6-23

[2]
Forty-Year Long-Term Outcome After Endoscopic and Open Surgery for Esthesioneuroblastoma in Consideration of Prognostic Factors.

Cancers (Basel). 2025-1-21

[3]
PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop.

Front Immunol. 2024

[4]
Survival Analysis and Prognostic Factors After Endonasal Resection of Advanced Olfactory Neuroblastomas: A Single Institution Experience.

J Otolaryngol Head Neck Surg. 2024

[5]
Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses.

J Transl Med. 2024-5-31

[6]
Genomic profiling and immune landscape of olfactory neuroblastoma in China.

Front Oncol. 2023-11-1

[7]
Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas.

J Pers Med. 2023-10-18

[8]
Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options.

Cancers (Basel). 2023-3-9

[9]
Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future.

Endocr Pathol. 2023-3

[10]
Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors.

Biomedicines. 2022-9-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索